Dashboard
Manage Tickers

LQDALiquidia Corp

Nasdaq liquidia.com


$ 9.85 $ 0.28 (2.92 %)    

Thursday, 29-Aug-2024 15:19:42 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 470.21 $ -2.50 (-0.53 %)
DIA $ 414.34 $ 3.00 (0.73 %)
SPY $ 558.43 $ -1.75 (-0.31 %)
TLT $ 97.50 $ -0.05 (-0.05 %)
GLD $ 233.13 $ 1.38 (0.6 %)
$ 9.54
$ 9.57
$ 9.84 x 200
-- x --
$ 9.53 - $ 9.86
$ 5.71 - $ 16.99
710,132
na
729.2M
$ 0.65
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-07-2024 06-30-2024 10-Q
2 05-13-2024 03-31-2024 10-Q
3 03-13-2024 12-31-2023 10-K
4 11-07-2023 09-30-2023 10-Q
5 08-10-2023 06-30-2023 10-Q
6 05-08-2023 03-31-2023 10-Q
7 03-20-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-12-2022 03-31-2022 10-Q
11 03-17-2022 12-31-2021 10-K
12 11-03-2021 09-30-2021 10-Q
13 08-10-2021 06-30-2021 10-Q
14 05-13-2021 03-31-2021 10-Q
15 03-25-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-liquidia-maintains-29-price-target
HC Wainwright & Co. Reiterates Buy on Liqu...
08/23/2024 11:17:43

HC Wainwright & Co. analyst Andrew Fein reiterates Liquidia (NASDAQ:LQDA) with a Buy and maintains $29 price target.

needham-reiterates-buy-on-liquidia-maintains-19-price-target
Needham Reiterates Buy on Liquidia, Mainta...
08/22/2024 16:02:31

Needham analyst Serge Belanger reiterates Liquidia (NASDAQ:LQDA) with a Buy and maintains $19 price target.

liquidia-has-filed-litigation-in-the-us-district-court-of-the-district-of-columbia-that-challenges-the-recent-fda-decision-to-grant-3-year-new-clinical-investigation-exclusivity-nci-exclusivity-to-tyvaso-dpi
Liquidia Has Filed Litigation In The U.S. ...
08/22/2024 10:05:32

FDA granted tentative approval of YUTREPIA (treprostinil) inhalation powder to treat pulmonary arterial hypertension (PAH) and ...

jim-cramer-praises-paypal-ceo-alex-chriss-financial-techs-have-come-back-in-style
Jim Cramer Praises PayPal CEO Alex Chriss:...
08/21/2024 13:23:11

PayPal CEO Alex Chriss "is a very good manager," Cramer said. Plus: AST SpaceMobile, Flutter Entertainment and more.

these-analysts-cut-their-forecasts-on-liquidia
These Analysts Cut Their Forecasts On Liqu...
08/20/2024 12:15:20

palo-alto-networks-to-rally-more-than-16-here-are-10-top-analyst-forecasts-for-tuesday
Palo Alto Networks To Rally More Than 16%?...
08/20/2024 11:53:39

btig-maintains-buy-on-liquidia-lowers-price-target-to-25
BTIG Maintains Buy on Liquidia, Lowers Pri...
08/20/2024 11:47:32

BTIG analyst Julian Harrison maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $29 to $25.

b-of-a-securities-maintains-buy-on-liquidia-lowers-price-target-to-23
B of A Securities Maintains Buy on Liquidi...
08/20/2024 11:29:07

B of A Securities analyst Greg Harrison maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $24 to ...

hc-wainwright--co-maintains-buy-on-liquidia-lowers-price-target-to-29
HC Wainwright & Co. Maintains Buy on Liqui...
08/20/2024 10:48:24

HC Wainwright & Co. analyst Andrew Fein maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $32...

nasdaq-surges-150-points-sonder-holdings-shares-surge
Nasdaq Surges 150 Points; Sonder Holdings ...
08/19/2024 18:37:19

why-nikola-shares-are-trading-lower-by-around-10-here-are-other-stocks-moving-in-mondays-mid-day-session
Why Nikola Shares Are Trading Lower By Aro...
08/19/2024 17:37:46

btig-maintains-buy-on-liquidia-lowers-price-target-to-25
BTIG Maintains Buy on Liquidia, Lowers Pri...
08/19/2024 17:31:14

BTIG analyst Julian Harrison maintains Liquidia (NASDAQ:LQDA) with a Buy and lowers the price target from $29 to $25.

raymond-james-upgrades-liquidia-to-strong-buy-maintains-price-target-to-27
Raymond James Upgrades Liquidia to Strong ...
08/19/2024 16:52:03

Raymond James analyst Ryan Deschner upgrades Liquidia (NASDAQ:LQDA) from Outperform to Strong Buy and maintains the price ta...

crude-oil-down-2-alzamend-neuro-shares-spike-higher
Crude Oil Down 2%; Alzamend Neuro Shares S...
08/19/2024 16:28:18

dow-jumps-over-100-points-estee-lauder-shares-edge-lower-after-q4-results
Dow Jumps Over 100 Points; Estee Lauder Sh...
08/19/2024 13:56:10

Core News & Articles
Market-Moving News for August 19th
08/19/2024 12:36:45

ALZN: 248% | Alzamend Neuro Partners With Massachusetts General Hospital For First-of-Its-Kind Phase II Study Of AL001 For PTSD...

liquidia-shake-shack-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Liquidia, Shake Shack And Other Big Stocks...
08/19/2024 12:27:36

needham-reiterates-buy-on-liquidia-maintains-25-price-target
Needham Reiterates Buy on Liquidia, Mainta...
08/19/2024 11:54:30

Needham analyst Serge Belanger reiterates Liquidia (NASDAQ:LQDA) with a Buy and maintains $25 price target.

liquidia-says-fda-granted-tentative-approval-of-yutrepia-treprostinil-inhalation-powder-to-treat-adults-with-pulmonary-arterial-hypertension-and-pulmonary-hypertension-associated-with-interstitial-lung-disease
Liquidia Says FDA Granted Tentative Approv...
08/19/2024 10:01:24

Tentative approval indicates that YUTREPIA has met all regulatory standards for quality, safety and efficacy required for appro...

raymond-james-initiates-coverage-on-liquidia-with-outperform-rating-announces-price-target-of-27
Raymond James Initiates Coverage On Liquid...
08/16/2024 11:41:33

Raymond James analyst Ryan Deschner initiates coverage on Liquidia (NASDAQ:LQDA) with a Outperform rating and announces Pric...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION